Form 13F security

REGN · Regeneron Pharmaceuticals, Inc.

Class COM

As filed on Form 13F — long US-listed positions only. No shorts, cash, bonds, or non-13F assets appear here.

Filed up to 45 days after quarter end; holdings may have changed since.

Tracked managers holding it

Share and principal positions

ManagerQuarterValue% of portfolioSH/PRN qtyPut/call
Dodge & Cox2026-06-30$3,037M1.6%SH 4,871,137
SOUTHEASTERN ASSET MANAGEMENT INC/TN/2026-06-30$95M5.0%SH 152,322
Bridgewater Associates, LP2026-06-30$32M0.1%SH 51,333
GAMCO INVESTORS, INC. ET AL2026-06-30<$1M<0.1%SH 657
HORIZON KINETICS ASSET MANAGEMENT LLC2026-06-30<$1M<0.1%SH 645

Total $3,165M across 5 of 69 managers.

Put positions

ManagerQuarterValue% of portfolioSH/PRN qtyPut/call
Point72 Asset Management, L.P.2026-06-30$0.6M<0.1%SH 1,000[PUT]

Total $0.6M across 1 of 69 managers.

Call positions

ManagerQuarterValue% of portfolioSH/PRN qtyPut/call
Point72 Asset Management, L.P.2026-06-30$0.6M<0.1%SH 1,000[CALL]

Total $0.6M across 1 of 69 managers.

Sums are across tracked reports, not unique economic ownership.

SOUTHEASTERN ASSET MANAGEMENT INC/TN/ — Combined report.

Filed rows (8) — as filed

The filer reports some securities in multiple rows; rows are shown as filed.

Quarter-to-quarter notes

Reported change, not a confirmed trade: this compares quarter-end reports filed up to 45 days later, and the position may since have changed. Amendments, corporate actions, and changes in reporting scope can also move these rows. Value change compares period-end reported values; for continuing rows it includes market price movement.

No longer reported by Fisher Asset Management, LLC — Ken Fisher, Point72 Asset Management, L.P..

Changes appear only where the prior quarter's validated report exists.